Home / Inspections / 1277627

FDA Inspection 1277627 — Aspire Fertility Institute McAllen

Aspire Fertility Institute McAllen — FEI 3013225167

The FDA completed an inspection of Aspire Fertility Institute McAllen on July 22, 2025 in Mcallen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 22, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mcallen, TX (United States)

Facility

Other inspections at this facility

  • 1175325 (NAI Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1076436 (NAI Mon Dec 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources